Exelixis Financial Ratios
EXEL / Health Care|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score 3.33 (safe zone, above 2.9 threshold)
- Strong profit margin: 29.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 31.4%
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
36.2%
ROE ranks in the above average among Health Care companies
Profit Margin
33.7%
Net Income / Revenue
Asset Turnover
0.82
Revenue / Total Assets
Equity Multiplier
1.32
Total Assets / Equity
Composite: 36.2% (reported: 36.2%)
Profitability
Liquidity
Current Ratio
3.56
Quick Ratio
3.50
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.82
Inventory Turnover
3.86
Days Sales Outstanding
-
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Earnings Quality
Accrual Ratio
-3.5%
+2.5pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.